CRLF2 Peptide Reference: GTX85439-PEP TSLP receptor peptide is used for blocking the activity of CRLF2 antibody (catalog number GTX85439). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human IFN-α 2b Reference: GFH52-20 Interferon-α 2b (IFN-α 2b) is a type I interferon made by leukocytes during viral infection. The JAK-STAT pathway mediates the antiviral and anti-cell proliferation activities of IFN-α 2b. IFN-α proteins are widely used as standard treatments during antiviral and antineoplastic therapies. The IFN-α 2b variant differs from IFN-α 2b by one amino acid.
STIM2 Peptide Reference: GTX85440-PEP STIM2 peptide is used for blocking the activity of STIM2 antibody (catalog number GTX8544). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human IFN-α 2b Reference: GFH52-100 Interferon-α 2b (IFN-α 2b) is a type I interferon made by leukocytes during viral infection. The JAK-STAT pathway mediates the antiviral and anti-cell proliferation activities of IFN-α 2b. IFN-α proteins are widely used as standard treatments during antiviral and antineoplastic therapies. The IFN-α 2b variant differs from IFN-α 2b by one amino acid.
STIM2 Peptide Reference: GTX85441-PEP STIM2 peptide is used for blocking the activity of STIM2 antibody (catalog number GTX85441). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human IFN-α 2b Reference: GFH52-250 Interferon-α 2b (IFN-α 2b) is a type I interferon made by leukocytes during viral infection. The JAK-STAT pathway mediates the antiviral and anti-cell proliferation activities of IFN-α 2b. IFN-α proteins are widely used as standard treatments during antiviral and antineoplastic therapies. The IFN-α 2b variant differs from IFN-α 2b by one amino acid.
ORAI3 Peptide Reference: GTX85442-PEP ORAI3 peptide is used for blocking the activity of ORAI3 antibody (catalog number GTX85442). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human IFN-α 2b Reference: GFH52-1000 Interferon-α 2b (IFN-α 2b) is a type I interferon made by leukocytes during viral infection. The JAK-STAT pathway mediates the antiviral and anti-cell proliferation activities of IFN-α 2b. IFN-α proteins are widely used as standard treatments during antiviral and antineoplastic therapies. The IFN-α 2b variant differs from IFN-α 2b by one amino acid.
ORAI2 Peptide Reference: GTX85443-PEP ORAI2 peptide is used for blocking the activity of ORAI2 antibody (catalog number GTX85443). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human IFN-γ Reference: GFH77-20 Interferon γ (IFN-γ) is a type II interferon that is critical during adaptive and innate immune responses to infection. IFN-γ is produced by T cells and Natural Killer cells following antigen-specific activation. IFN-γ binds IFN-γ receptors (IFN-γ R1 and IFN-γ R2), which are expressed on most immune cells, to activate the JAK-STAT pathway. IFN-γ induced signaling increases the expression of class 1 major histocompatibility complex (MHC) molecules. Human IFN-γ is not cross-reactive with mouse IFN-γ.
NPAS3 Peptide Reference: GTX85444-PEP NPAS3 peptide is used for blocking the activity of NPAS3 antibody (CatNo. GTX85444). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human IFN-γ Reference: GFH77-100 Interferon γ (IFN-γ) is a type II interferon that is critical during adaptive and innate immune responses to infection. IFN-γ is produced by T cells and Natural Killer cells following antigen-specific activation. IFN-γ binds IFN-γ receptors (IFN-γ R1 and IFN-γ R2), which are expressed on most immune cells, to activate the JAK-STAT pathway. IFN-γ induced signaling increases the expression of class 1 major histocompatibility complex (MHC) molecules. Human IFN-γ is not cross-reactive with mouse IFN-γ.